The Defense Health Agency (DHA) is seeking to award a sole source firm-fixed price Purchase Order contract for a wet integrated chemistry analyzer, specifically from Roche Diagnostics Corporation. The procurement aims to acquire a specialized analyzer that combines clinical chemistry, immunochemistry, and ISE testing, featuring capabilities such as autocalibration, high analytical sensitivity, and the ability to process various cardiac assays and metabolic panels efficiently. This equipment is crucial for timely and accurate laboratory testing, ensuring compliance with regulatory standards. Interested parties must submit a capabilities statement by 10:00 AM Eastern Time on February 11, 2025, to Gillian Dell at gillian.j.dell.civ@health.mil, referencing HT940625Q0023.